Effect of energy-rich compounds on release of intracellular enzymes from human leukocytes and rat lymphocytes.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D003402:Creatine Kinase / Q000378:metabolism; D003470:Culture Media; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007094:Imides / Q000494:pharmacology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007962:Leukocytes / Q000187:drug effects / Q000201:enzymology*; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology*; D008291:Malate Dehydrogenase / Q000378:metabolism; D010725:Phosphocreatine / Q000494:pharmacology; D010728:Phosphoenolpyruvate / Q000494:pharmacology; D010756:Phosphoric Acids / Q000494:pharmacology; D010770:Phosphotransferases / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011770:Pyruvate Kinase / Q000378:metabolism; D051381:Rats; D014500:Uracil Nucleotides / Q000494:pharmacology
D003470:Culture Media; D007094:Imides; D010756:Phosphoric Acids; D014500:Uracil Nucleotides; D010725:Phosphocreatine; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D010728:Phosphoenolpyruvate; D000255:Adenosine Triphosphate; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D001219:Aspartate Aminotransferases; D010770:Phosphotransferases; D011770:Pyruvate Kinase; D003402:Creatine Kinase; D005947:Glucose; D011188:Potassium